(Q38543451)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26150100%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

review article

1 reference

title

Adenosine as an Adjunct Therapy in ST Elevation Myocardial Infarction Patients: Myth or Truth? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26150100%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author

Giovanni Luigi De Maria

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26150100%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Rajesh K Kharbanda

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26150100%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Adrian Banning

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26150100%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

George Kassimis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26150100%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Periklis Davlouros

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26150100%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Niket Patel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26150100%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Manolis S Kallistratos

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26150100%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Athanasios J Manolis

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26150100%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Dimitrios Alexopoulos

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26150100%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

publication date

1 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26150100%20AND%20SRC:MED&resulttype=core&format=json

Cardiovascular Drugs and Therapy

18 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26150100%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26150100%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26150100%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

page(s)

481-493

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26150100%20AND%20SRC:MED&resulttype=core&format=json

Coronary and myocardial angiography: angiographic assessment of both epicardial and myocardial perfusion

18 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Myocardial no-reflow in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Temporal evolution and functional outcome of no reflow: sustained and spontaneously reversible patterns following successful coronary recanalisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Society of cardiac angiography and interventions: Suggested management of the no‐reflow phenomenon in the cardiac catheterization laboratory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Coronary flow velocity analysis during short term follow up after coronary reperfusion: use of transthoracic Doppler echocardiography to predict regional wall motion recovery in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Serial evaluation of perfusion defects in patients with a first acute myocardial infarction referred for primary PTCA using intravenous myocardial contrast echocardiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Early change in invasive measures of microvascular function can predict myocardial recovery following PCI for ST-elevation myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Reperfusion syndrome: relationship of coronary blood flow reserve to left ventricular function and infarct size

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Incomplete Resolution of ST-Segment Elevation Is a Marker of Transient Microcirculatory Dysfunction After Stenting for Acute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Microvascular Resistance Predicts Myocardial Salvage and Infarct Characteristics in ST-Elevation Myocardial Infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

No-reflow phenomenon: maintaining vascular integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Novel insights into an "old" phenomenon: the no reflow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Antagonism of selectin function attenuates microvascular platelet deposition and platelet-mediated myocardial injury after transient ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Antagonism of P2Y12 or GPIIb/IIIa receptors reduces platelet-mediated myocardial injury after ischaemia and reperfusion in isolated rat hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Platelets activated by transient coronary occlusion exacerbate ischemia-reperfusion injury in rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Thrombin increases cardiomyocyte acute cell death after ischemia and reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Thrombus aspiration during primary percutaneous coronary intervention improves myocardial reperfusion and reduces infarct size: the EXPIRA (thrombectomy with export catheter in infarct-related artery during primary percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Thrombus aspiration during ST-segment elevation myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Thrombus aspiration during primary percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Impact of thrombus aspiration during primary percutaneous coronary intervention in cardiogenic shock complicating ST-segment elevation myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Role of aspiration and mechanical thrombectomy in patients with acute myocardial infarction undergoing primary angioplasty: an updated meta-analysis of randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

A meta-analytic overview of thrombectomy during primary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Randomized trial of primary PCI with or without routine manual thrombectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Comparison of intracoronary vs. intravenous administration of abciximab in coronary stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Bivalirudin for patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Bivalirudin during primary PCI in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Intracoronary verapamil for reversal of no-reflow during coronary angioplasty for acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Short-term effect of verapamil on coronary no-reflow associated with percutaneous coronary intervention in patients with acute coronary syndrome: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Resolution of refractory no-reflow with intracoronary epinephrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Intracoronary pharmacotherapy in the management of coronary microvascular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Comparison of the effects of nitroprusside versus nicorandil on the slow/no-reflow phenomenon during coronary interventions for acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Treatment of slow/no-reflow phenomenon with intracoronary nitroprusside injection in primary coronary intervention for acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Impact of PercuSurge device conjugative with intracoronary administration of nitroprusside on no-reflow phenomenon following primary percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Effect of intracoronary adenosine infusion during coronary intervention on myocardial reperfusion injury in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Improvement in microvascular reflow and reduction of infarct size with adenosine in patients undergoing primary coronary stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Left ventricular remodeling after primary coronary angioplasty in patients treated with abciximab or intracoronary adenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis, results of the ATTenuation by Adenosine of Cardiac Complications (ATTACC) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

High dose adenosine for suboptimal myocardial reperfusion after primary PCI: A randomized placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Prospective, randomised, controlled trial to study the effect of intracoronary injection of verapamil and adenosine on coronary blood flow during percutaneous coronary intervention in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Ticagrelor inhibits adenosine uptake in vitro and enhances adenosine-mediated hyperemia responses in a canine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Ticagrelor increases adenosine plasma concentration in patients with an acute coronary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Comparing the effect of clopidogrel versus ticagrelor on coronary microvascular dysfunction in acute coronary syndrome patients (TIME trial): study protocol for a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Effect of cyclosporine on reperfusion injury in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Post-conditioning reduces infarct size and edema in patients with ST-segment elevation myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

The salvage potential of coronary sinus interventions: meta-analysis and pathophysiologic consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribu

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Role of adenosine as adjunctive therapy in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Adenosine: physiology, pharmacology, and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Adenosine stimulates angiogenesis by up-regulating production of thrombospondin-1 by macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

The cGMP/PKG pathway as a common mediator of cardioprotection: translatability and mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Modulation of cardiac remodeling by adenosine: in vitro and in vivo effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Adenosine therapy: a new approach to chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Intravenous adenosine and lidocaine in patients with acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD-2 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Exogenous adenosine triphosphate disodium administration during primary percutaneous coronary intervention reduces no-reflow and preserves left ventricular function in patients with acute anterior myocardial infarction: a study using myocardial cont

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Left ventricular remodeling and 1-year clinical follow-up of the REOPEN-AMI trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Adenosine improves post-procedural coronary flow but not clinical outcomes in patients with acute coronary syndrome: a meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Intracoronary injection of adenosine before reperfusion in patients with ST-segment elevation myocardial infarction: a randomized controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

The REFLO-STEMI trial comparing intracoronary adenosine, sodium nitroprusside and standard therapy for the attenuation of infarct size and microvascular obstruction during primary percutaneous coronary intervention: study protocol for a randomised c

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Intracoronary Compared With Intravenous Bolus Abciximab Application in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5

Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-015-6606-5